Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :CO2

    
• • ·Instructions to Authors

    Page :I

    

• Editorial

  • ·How Cool is Cryoablation?

    Page :425-426

    Stuart P. Thomas

    

• Original Articles

  • ·Treating Atrial Fibrillation: Pulmonary Vein Isolation with the Cryoballoon Technique

    Page :427-432

    Nick Jackson, Malcolm Barlow, James Leitch, John Attia

    Résumé Résumé Plan Plan  
  • ·Does Pregnancy Contribute to Systemic Right Ventricular Dysfunction in Adults with an Atrial Switch Operation?

    Page :433-438

    Dominica Zentner, Miriam Wheeler, Leeanne Grigg

    Résumé Résumé Plan Plan
  • ·A Comparison of Precipitants and Mortality When Acute Decompensated Heart Failure Occurs in the Community and Hospital Settings

    Page :439-443

    D.McD. Taylor, M. Ng Tang Fui, A.R. Chung, L. Gani, J.D. Zajac, L.M. Burrell

    Résumé Résumé Plan Plan
  • ·Single High Oral Dose Amiodarone for Cardioversion of Recent Onset Atrial Fibrillation

    Page :444-448

    Kugathasan Nadarasa, Michael J.A. Williams

    Résumé Résumé Plan Plan  

• Reviews

  • ·A Suggested Paradigm for Coronary Risk Screening in Asymptomatic Persons—Assessment of Total Coronary Atheromatous Burden

    Page :449-454

    Constantine N. Aroney

    Résumé Résumé Plan Plan  
  • ·Assessment of Platelet Function in Patients on Antiplatelet Therapy Undergoing Cardiac Surgery: A Review

    Page :455-462

    Ravi Patni, M. Asghar Nawaz, Antanas Macys, K.M. John Chan, P. Punjabi

    Résumé Résumé Plan Plan  
  • ·Novel Anticoagulants for Non-valvular Atrial Fibrillation

    Page :463-467

    Bo Xu, Robert Whitbourn

    Résumé Résumé Plan Plan  
  • ·Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation?

    Page :468-479

    Suchi Grover, Govin Srinivasan, Joseph B. Selvanayagam

    Résumé Résumé Plan Plan  

• Abstracts of The Cardiac Society of New Zealand, New Zealand Annual Scientific Meeting, 15-17 June 2012, Auckland, New Zealand

  • ·Medium-Term Follow up of Transcoronary Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

    Page :481

    P.D. Adamson, D. Smyth, J. Lainchbury

    
  • ·The Evaluation of Documentation in a Nurse and Medical Post Acute Coronary Syndrome Discharge Clinic

    Page :481

    C. Aldridge, A. Kerr, S. Oster, A. McLachlan

    
  • ·Ablation of Ventricular Tachycardia at Waikato Hospital

    Page :481-482

    R.F. Allen, S.C. Heald, D. Boddington, M.R. Webber, M.K. Stiles

    
  • ·Clinical Utilisation of Pro-BNP in the Exclusion of Congestive Heart Failure (CHF)

    Page :482

    C. Tromop van Dalen, A. Falloon, T. Boga

    
  • ·Urocortin-2 Increases Muscle Sympathetic Nerve Activity [MSNA] in Healthy Man

    Page :482

    W. Chan, D. Jardine, J. Butler, C. Charles, R. Troughton, M. Richards

    
  • ·Twenty-one Cases of Stress Cardiomyopathy Following the Christchurch, New Zealand 2011 Earthquake—Self Reported Health Outcome at 1 Year

    Page :482-483

    C. Chan, P. Bridgman, R. Troughton, J. Elliott

    
  • ·Integrated Effects of Urocortin-2 Infusion in Patients with Acute Decompensated Heart Failure: Findings from a Randomised Controlled Clinical Trial

    Page :483

    W. Chan, R. Troughton, C. Frampton, I. Crozier, M. Richards

    
  • ·Comparison of the Multiplate and VerifyNow Assays for Monitoring Residual Platelet Reactivity after Clopidogrel

    Page :483-484

    M. Chen-Xu, L. Johnston, A. Holley, A. Sasse, P.D. Larsen, S.A. Harding

     
  • ·Elevated Plasma Active Matrix Metalloproteinase 9 Level is Associated with Increased Diastolic Dysfunction Independent of Hypertension and Left Ventricular Hypertrophy in Patients with Coronary Artery

    Page :484

    J.W. Chu, G.T. Jones, G.P. Tarr, L.V. Phillips, G.T. Wilkins, A.M. van Rij, M.J.A. Williams

    
  • ·Valvular Heart Disease Mortality in New Zealand 1988 to 2007

    Page :484

    S. Coffey, B. Cox, M.J.A. Williams

    
  • ·Prognostic Value of Stress Perfusion Imaging with Cardiac MRI

    Page :484-485

    P. Ding, C. Edwards, A. To, J.P. Christiansen

     
  • ·One Year Outcomes after Treatment of Acute Myocardial Infarction (AMI) in 2010 are Improved Compared with Previous Years

    Page :485

    R. Lane, G. Campbell, C.M. Frampton, D.W. Smyth, J.M. Elliott

    
  • ·Is a “Small” Heart Attack a “Good” Heart Attack? One Year Outcomes after Acute Myocardial Infarction (AMI) in 2010 in Relation to Biomarker Elevations

    Page :485-486

    J.M. Elliott, R. Lane

    
  • ·Costly Time Delays for Weekend Acute Coronary Syndrome (ACS) Patient Admissions: Implications for Service Delivery

    Page :486

    C.J. Ellis, P. Horan, M. Gordon, G. Gamble

     
  • ·Factors Which Predict Individuals Whose Coronary Arteries are “Old Before Their Time”: The Value of Computed Tomographic (CT) Calcium Score Testing

    Page :486-487

    C.J. Ellis, M.E. Legget, C. Edwards, J.A. Ormiston, N. Van Pelt, R. Gabriel, B. Lowe, J. Christiansen, H. Winch, M. Osborne, G. Gamble

    
  • ·All Cause Mortality Following an Acute Coronary Syndrome (ACS) Admission: Six Year Follow-Up of the 2002 New Zealand (NZ) Acute Coronary Syndromes Audit

    Page :487-488

    C.J. Ellis, G.D. Gamble, G. Devlin, A. Hamer, J.M. Elliott, P. Matsis, M.J.A. Williams, S. Mann, J.K. French, A.M. Richards, H.D. White, For the Cardiac Society NZ ACS Audit Group

     
  • ·Is the Mortality Risk Following an Acute Coronary Syndrome (ACS) Admission to a Non-intervention Centre Related to Access to Cardiac Angiography? Eighteen Month Follow-up of the 2002/2007 New Zealand (NZ) ACS Audits

    Page :488

    CJ. Ellis, G.D. Gamble, A. Hamer, G. Devlin, J.M. Elliott, P. Matsis, M.J.A. Williams, S. Mann, J.K. French, A.M. Richards, H.D. White, For the Cardiac Society NZ ACS Audit Group

     
  • ·Acute Predict Cardiac Catheter Lab (CCL) One Year on—An Electronic Real-Time Audit, Quality Improvement Process in Middlemore Hospital CCL

    Page :489

    C. Flynn, J. White, S. Graham, A. McLachlan, D. Scott, P. Kay, A.J. Kerr

    
  • ·Reveal Loop Recorders—Should Follow Up Frequency be Driven by Patient Symptoms?

    Page :489

    M. Fowler, F. Riddell

    
  • ·Mortality, Morbidity and the Current Standard of Evidence-based Management Amongst Patients Living in Regional New Zealand with Severe Heart Failure (1997–2011): The Nelson Marlborough Heart Failure Study

    Page :489-490

    B.T. Grainger, S. White, S. Lake, R. Hipkiss, A. Hamer, N. Fisher, T. Pegg

    
  • ·Prognostic Utility of Cardiac Troponin in Patients with Possible Acute Coronary Syndromes Categorised by Degree of Coronary Artery Stenosis

    Page :490

    J.W. Hinton, A. McNally, S. Aldous

    
  • ·Plasma Antioxidant Enzyme Levels in Acute Coronary Syndrome

    Page :490

    A.S. Holley, L.R. Johnston, M. Chen-Xu, A. Sasse, P.D. Larsen, S.A. Harding

    
  • ·Subcutaneous ICDs and Shock Therapy: Lessons Learned

    Page :490-491

    M.A. Hood, F. Riddell, W.M. Smith

    
  • ·A Dedicated Cardiovascular Quality Assurance Programme in the Catheterisation Laboratory: A Novel Experience in New Zealand

    Page :491

    H.C. Humphreys, M. McAleer, S. El-Jack

    
  • ·High Residual Platelet Reactivity on Aspirin in a New Zealand ACS Population

    Page :491-492

    L.R. Johnston, A.S. Holley, M. Chen-Xu, A.C. La Flamme, D. Larsen, S.A. Harding

     
  • ·Variability in Platelet Reactivity and Biomarkers in Patients With Peripheral Vascular Disease

    Page :492

    L.R. Johnston, A.C. La Flamme, J.K. Wicks, D. Naik, P.D. Larsen, S.A. Harding

    
  • ·Eicosapentaenoic Acid Increases Plasma Adiponectin Concentration in Patients with Hyperlipidaema

    Page :492-493

    Y. Kajikawa, S. Takemoto, M. Ikeda

    
  • ·Role of CTCA in Acute Coronary Syndrome—Predicting Non-Significant Coronary Artery Disease

    Page :493

    S.H. Kueh, M. Lee, A.J. Kerr, N. van Pelt

    
  • ·Geographic, Ethnic and Socioeconomic Factors Influencing Access to Implantable-Cardioverter Defibrillators

    Page :493

    P.D. Larsen, D. Wilson, S.A. Harding, I. Melton, N.A. Lever, D. Boddington, S. Heald, M.K. Stiles

    
  • ·Estimating the Need for Implantable Cardioverter Defibrillators

    Page :494

    P.D. Larsen, L. Presant, S.A. Harding

    
  • ·ICD Therapy in Patients with Mustard and Senning Repair for D-Transposition of Great Arteries. The Greenlane/Auckland Hospital Experience

    Page :494

    M. Latif, B. Lowe

    
  • ·Cardiac Function in COPD Exacerbations

    Page :494-495

    M. Lee, A. Davies, C. Chang, M. Davis, R. Hancox

    
  • ·Percutaneous Lead Extraction: MDT Team Approach in Cardiac Catheter Labs

    Page :495

    N.A. Lever, J. Manson, R. Ullal, R. Cameron, S. Heald

    
  • ·Ambulatory Management of Congestive Heart Failure in the Rotorua and Taupo Communities

    Page :495

    S. Li, D. Aitken

    
  • ·Do Acute Coronary Syndrome Patients Categorised at High Risk by Grace Receive More Frequent and Earlier Coronary Angiography?

    Page :496

    A. Lin, A. Mustafa, G. Devlin, M. Lee, A. McLachlan, A.J. Kerr

    
  • ·How Well Does the Grace Score Perform in a New Zealand Acute Coronary Syndrome Cohort?

    Page :496

    A. Lin, A. Mustafa, M. Lee, G. Devlin, I. Ternouth, A. McLachlan, A.J. Kerr, on behalf of the all NZ ACS (ANZACS) QI group

    
  • ·Primary Percutaneous Coronary Intervention for Patients with St Elevation Myocardial Infarction—Past and Present at Auckland City Hospital

    Page :496-497

    A. Lin, J.L. Looi, K.L. Looi, K.L. Chow, F. Roberts, H.D. White, M. Webster, C.J. Ellis

     
  • ·Aortic–Mitral Annular Coupling in Mitral Valve Diseases: A Study with Real-Time 3-Dimensional Transoesophageal Echocardiography (RT3DE-TEE)

    Page :497-498

    J.L. Looi, Y.Y. Lam, C.M. Yu, P.W. Lee

     
  • ·Aortic–Mitral Annular Coupling Before and After Mitral Valve Repair: A Study with Real-Time Three-Dimensional Transoesophageal Echocardiography (RT3DE-TEE)

    Page :498

    J.L. Looi, Y.Y. Lam, C.M. Yu, P.W. Lee

     
  • ·Compulsory Collection of Key Performance Indicators at Point of Discharge Planning at Nelson Marlborough District Health Board: Do We Need It?

    Page :499

    K. Majeed, T. Pegg, N. Fisher, A. Hamer

    
  • ·Long-Term Effects of Cardiac Rehabilitation on Exercise Capacity and Cardiovascular Function in Coronary Artery Disease

    Page :499

    S. Mandic, M.J.A. Williams, E. Stevens, C. Brown, E.R. Nye, D. Body, L. Barclay, R. Walker

    
  • ·Effects of Community-Based Cardiac Rehabilitation on Physical Function and Body Composition in Coronary Artery Disease: 1.5-Year Follow-Up

    Page :499-500

    S. Mandic, C. Hodge, E. Stevens, H. Horwood, R. Walker, E.R. Nye, D. Body, M.J.A. Williams

    
  • ·A Decade of Cardiac Resynchronisation Therapy: The Green Lane and Auckland City Hospital Experience

    Page :500

    A. Martin, S. Sinclair, M. Hood, N. Lever, J. Stewart

    
  • ·Quality of Life Results after Insertion of Implantable Cardiac Defibrillators at Christchurch Hospital

    Page :500

    S. Matthewson, I. Crozier, J. Greenslade, K. Harvey, J. Inglis, I. Melton

    
  • ·Predictors of Mortality in the ICD Population

    Page :501

    R. McIntosh, P.-W. Lou, B. Shi, S.A. Harding, P.D. Larsen

     
  • ·Internet and Social Networking Use Amongst Patients Attending a South Auckland Cardiac Rehabilitation Program

    Page :501

    A. McLachlan, C. Aldridge, L. Ioelu, M. Morgan, K. McLean, L. Morley, J. Poole, A.J. Kerr

    
  • ·Will a High Dose Lipid Lowering Strategy be Tolerated by Both Patients and Clinicians; A Retrospective Audit

    Page :501-502

    A. Mclachlan, K. McLean, A.J. Kerr, A.P. Shanmuganathan

    
  • ·The Design and Implementation of a Pacific Cardiac Rehabilitation Program in South Auckland: The First Year

    Page :502

    K. McLean, L. Ioelu, L. Morley, A. McLachlan

    
  • ·Early Experience of Dabigatran Use in a Wellington Population

    Page :502

    J. Michel, D. Mundell, T. Boga, A. Sasse

    
  • ·New Zealand Cardiac Clinical Prioritisation System: Left Ventricular Impairment Predicts ICU Length of Stay after Coronary Artery Bypass Graft Surgery

    Page :503

    J.M. Michel, N.M. Shah, G. Ashton, A. Psirides, B.D. Mahon, P.D. Larsen, A.S. Sasse

     
  • ·Does EuroSCORE Predict Preoperative Complications in Patients Awaiting Coronary Artery Bypass Surgery: Lessons from the Clinical Cardiac Prioritisation System Database

    Page :503-504

    J.M. Michel, N.M. Shah, G. Ashton, A. Psirides, B.D. Mahon, A.S. Sasse

     
  • ·Evaluation of the Middlemore Hospital Cardiac Rehabilitation (CR) Exercise Program

    Page :504

    M. Morgan, I. Zeng, A. McLachlan

    
  • ·Strain and Pacing Study; Role of Pacing Lead Placement in LV Contraction

    Page :504-505

    A.M. Morgan, M. Webber, S. Harding, A. Scully, J. Sexton, L. Johnson, P. Larsen, A. Sasse

    
  • ·A Quality Improvement Process: Pacific Community Focused Cardiac Rehabilitation

    Page :505

    L. Morley, K. McLean, A. McLachlan

    
  • ·Role of Cardiac MRI in Patients Presenting with Acute Coronary Syndrome with Normal or Minor Coronary Artery Disease

    Page :505

    D. Mundell, T. Boga, K. Ferrier

    
  • ·Thrombolysis in STEMI: A Two-Year Clinical Experience in Tauranga Hospital

    Page :505-506

    A.H.S. Mustafa, N. Wijesuriya, G.F. Porter, J. Tisch, C. Young, D. Boddington, S. Tie

    
  • ·Ethnicity and Revascularisation Following Acute Coronary Syndromes: A Four-Year Cohort Study

    Page :506

    A.H.S. Mustafa, A. Lin, M. Lee, A. McLachlan, A.J. Kerr

    
  • ·The Impact of Direct ECG Transmission from Ambulance to Cardiologist on PAMI Treatment Delays

    Page :506

    C.M. Nunn, G.P. Devlin

     
  • ·Surgical Repair of Adult Coarctation in Auckland

    Page :506-507

    T. Oh, K. Finucane

    
  • ·“Between a Rock and a Hard Place”: Post ICD Shock Stress Reactions

    Page :507

    M.L. Garland, L. Painter, M. Johnson, N. Lever

    
  • ·The Shocking Truth: Psychological Impact of Shocks and Storms for Implantable Cardioverter Defibrillator (ICD) Patients

    Page :507

    M.L. Garland, L. Painter, M. Johnson, N. Lever

    
  • ·Medtronic Carelink Remote Monitoring the Auckland City Hospital (ACH) Setup Experience

    Page :508

    C. Pearson, S. Sinclair, F. Riddell

     
  • ·Ability of General Physician to Correctly Interpret Pacing Indications

    Page :508-509

    J. Pemberton

    
  • ·Prognostic Significance of Atrial Fibrillation in Acute Heart Failure Admissions: The New Zealand Heart Failure Registry

    Page :509

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Prevalence of Hyponatraemia in Acute Heart Failure Admissions and Short Term Outcomes: The New Zealand Heart Failure Registry

    Page :509

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Gender Differences in Acute Heart Failure Admissions and Short Term Outcomes: The New Zealand Heart Failure Registry

    Page :510

    V. Pera, R. Troughton, M. Lund, R. Doughty, G. Devlin, on behalf of the NZHFR Investigators

    
  • ·Reviewing the Use of Pre-Hospital ECG in Management of Patients with Suspected ST Elevation Myocardial Infarction (STEMI)

    Page :510

    S. Plunkett, T. O’Meeghan, T. Boga

    
  • ·Apical Ballooning Syndrome and Stress

    Page :510-511

    J. Poole, J. Main, C. Roberts, L. Morley, I. Zeng, K. McLean, C. Aldridge, A. Kerr, A. McLachlan

    
  • ·The Prediction of Fat Free Mass for Indexation of Echo Measurements

    Page :511

    K.K. Poppe, R.N. Doughty, G.A. Whalley, C.M. Triggs

     
  • ·Improved Cardiovascular Risk Estimation in People with Type 2 Diabetes Mellitus: Potential Role of Specialised Risk Equations and CT Coronary Calcium Score

    Page :511-512

    K.K. Poppe, N. van Pelt, S. Bhattacharyya, G.A. Whalley, R.N. Doughty

     
  • ·Aortic and Left Ventricular Function During Rest and Exercise Using Magnetic Resonance Imaging

    Page :512

    P.A. Roberts, M. Peters, A. Okamura, Y. Liu, B. Cowan, A. Young

    Plan Plan
  • ·Similar Long-Term Outcomes After ST Elevation Myocardial Infarction Treated with Everolimus Eluting Stents or Bare Metal Stents

    Page :512-513

    R.R. Saireddy, J. Elliott, D. Smyth, D. McClean, J. Blake

    
  • ·Validation Study of Cardiac Clinical Prioritisation Score (CPS) for Coronary Artery Bypass Grafting

    Page :513

    A.S. Sasse, J.M. Michel, N.M. Shah, G. Ashton, S.A. Harding, B.D. Mahon, P.D. Larsen

    
  • ·Do Cardiovascular Risk Factors Predict Complications in Patients Awaiting Coronary Artery Bypass Grafting

    Page :513-514

    N.M. Shah, J.M. Michel, G. Ashton, A. Psirides, B.D. Mahon, P.D. Larsen, A.S. Sasse

     
  • ·Complex Transradial Percutaneous Coronary Intervention Using a Sheathless Guide Catheter

    Page :514

    N.M. Shah, A.S. Sasse, P.P. Matsis, P.D. Larsen, S.A. Harding

    
  • ·ECG Markers of Arrhythmogeneic Substrate and Structural Heart Disease

    Page :514

    B. Shi, K. Ferrier, A. Sasse, S.A. Harding, P.D. Larsen

    
  • ·Predictors of Intervention in Acute Coronary Syndrome Patients with pre-Existing Bypass Grafts

    Page :515

    T.A.C. Snow, T. Watson, P.N. Ruygrok, M.W. Webster, J.T. Stewart

    
  • ·The Predictive Value of Microvolt T Wave Alternans in Patients with Implanted Defibrillators

    Page :515

    J.A. Sutherand, I.C. Melton, H.J. Earl, K.P. Dredge, S.J. Aldous, S. Matthewson, I.G. Crozier

    
  • ·Medium Term Success Rates of Pulmonary Vein Isolation for Atrial Fibrillation

    Page :515-516

    J. Swampillai, I. Gray, M.R. Webber, D. Boddington, S.C. Heald, M.K. Stiles

    
  • ·Diagnostic Yield of Implantable Loop Recorders in Patients with Unexplained Syncope

    Page :516

    J. Swampillai, R.F. Allen, S. Levings, M.R. Webber, C.M. Wade, M.K. Stiles, S.C. Heald

    
  • ·Use of Exercise Tolerance Test in Intermediate Risk non-ST Elevation Acute Coronary Syndrome

    Page :516

    P. Tamuno, J. Mazhar, J. Swampillai, V. Pera, A. Kerr, G. Devlin

    
  • ·Single Versus Multi-Vessel PCI in STEMI Patients with Multivessel Coronary Artery Disease in Dunedin Public Hospital

    Page :517

    C.L.H. Tie, V.H.T. Chen, G.T. Wilkins, M.J.A. Williams, C.K. Wong, P. Herbison, E.C. McKay, L. Vardi, A. Middleton

    
  • ·The Essential Roles of Nurse Specialist in Delivering CT Coronary Angiography Service in the Acute Chest Pain Setting

    Page :517

    J. Wickham, H. Brannigan, J. Carr, J.P. Christiansen, C. Edwards, D. Cranefield, H.H. Hart, A.C.Y. To

    
  • ·Incorporating CT Coronary Angiography in the Acute Chest Pain Pathway—An Efficient Model of Resource Utilisation

    Page :517-518

    A.C.Y. To, J.P. Christiansen, C. Edwards, D. Cranefield, H.H. Hart, J. Wickham

    
  • ·Delay to Surgical Revascularisation Post Acute Coronary Syndromes—Middlemore Hospital

    Page :518

    J. Voss, I. Caldwell, A. Kerr

    
  • ·Early Prevent Pilot: Towards the Systemic Use of Dispensing Records to Prevent Treatment Gaps Early After Acute Coronary Syndromes-Proof of Concept

    Page :518

    J. Voss, A. McLachlan, T. Riddell, S. Bhattacharya, J. Warren, A.J. Kerr

    
  • ·Mitral Valve Endocarditis Audit—Auckland City Hospital

    Page :518-519

    J. Voss, S. Chung, C. Kasargod, J. Pemberton

    
  • ·Bone Density Before and After Heart or Lung Transplantation—A Longitudinal Study

    Page :519

    T.K.M. Wang, S. O’Sullivan, G.D. Gamble, P.N. Ruygrok

    
  • ·New Parenthood After Heart Transplantation

    Page :519

    A. Ruygrok, H. Gibbs, E. Painter, A. Coverdale, P. Ruygrok, C. Wasywich

    
  • ·Same-Day Discharge is Safe in Patients with Low-Level Troponin Elevation post-PCI

    Page :520

    I.G. Webb, M.B. Simmonds, P.D. Larsen, S.A. Harding

    
  • ·Elevated Baseline Cardiac Troponin Levels in the Elderly—Another Variable to Consider?

    Page :520-521

    I.G. Webb, S.T. Yam, R. Cooke, A. Aitken, P.D. Larsen, S.A. Harding

     
  • ·Implantable Cardioverter Defibrillator Registry in New Zealand—Initial Experience

    Page :521

    H.S. Millow, M.R. Webber, P.D. Larsen, S.A. Harding, S.C. Heald, M.K. Stiles

    
  • ·Prevalence of Atrial Fibrillation in Maori and non-Maori Inpatients in the Waikato Region

    Page :521-522

    M.R. Webber, M. Mannakarra, J. Swampillai, I. Gray, M.K. Stiles

    
  • ·Periprocedural Dabigatran in Patients Undergoing Electrophysiology Procedures

    Page :522

    M.R. Webber, I. Gray, M.K. Stiles

    
  • ·Significant Bias Associated with Left Ventricular Volume Measurements by MRI Compared to Echo (2D, 2D-Contrast and 3D)—A Systematic Review

    Page :522-523

    S. Anandabaskaran, J. Christiansen, R. Doughty, R. Gabriel, G. Whalley

    
  • ·Implantable Cardioverter Defibrillator (ICE) Use in Hypertrophic Cardiomyopathy—Ten-Year Auckland Experience

    Page :523

    J. White, S. Sinclair, F. Riddell, M. Hood, N. Lever, W. Smith

    
  • ·Safety of Conscious Sedation for Cardiology Procedures at Auckland Hospital

    Page :523

    J. White, A. Martin, N. Lever

    
  • ·Excessive Cardiovascular Risk and Cardiac Investigations in Asymptomatic Population: A Study in Airline Pilots

    Page :524

    I.M.A. Wirawan, S. Aldington, R.F. Griffiths, C.J. Ellis, P.D. Larsen

    
  • ·Vitamins B₁₂ and C Supplementation Improves Arterial Reactivity and Structure in Passive Smokers

    Page :524

    K.S. Woo, P. Chook, M.L. Chiu, X.H. Feng, M.L. Evora, K.V. Koon, X.M. Zhang, C.L. Chu, H.C. Leong, T.W.C. Yip, T.Y.K. Chan

    
  • ·VF Waveform Complexity at ICD Implant is Predictive of Future ICD Therapy

    Page :525

    E.L. Woodcock, N.A. Lever, P.D. Larsen

     
  • ·Ventricular Fibrillation Characteristics: What Measurements are Best?

    Page :525

    E.L. Woodcock, N.A. Lever, P.D. Larsen

    
  • ·Must Low Risk Radial Access Coronary Angiography Outweigh Potentially High Risk Femoral Access as an Approach of Choice? Experiences from Four Years of Angiography and Intervention at North Shore Hospital

    Page :525-526

    M.B. McAleer, S. El-Jack, B. O’Shaughnessy

    

• Societies

  • ·Heart Foundation

    Page :527

    
  • ·The Cardiac Society of Australia and New Zealand

    Page :528-529